TickerFacts.

Ligand Pharmaceuticals Inc (LGND): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Older than the company's other figures. The latest Gross Profit is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$103.40M
Year ended 2016-12-31
+33.7%
3-year compound annual growth
+32.7%
5-year compound annual growth
2011-12-31: $25.13M2012-12-31: $27.79M2013-12-31: $43.24M2014-12-31: $55.40M2015-12-31: $66.11M2016-12-31: $103.40M$103.40M
2011-12-31 Gross Profit (USD) 2016-12-31
Period endedGross ProfitChange YoYSource filing
2016-12-31$103.40M+56.4%2019-02-28, From 2016-01-01
2015-12-31$66.11M+19.3%2018-03-01, From 2015-01-01
2014-12-31$55.40M+28.1%2017-02-28, From 2014-01-01
2013-12-31$43.24M+55.6%2016-11-14, From 2013-01-01
2012-12-31$27.79M+10.6%2015-02-23, From 2012-01-01
2011-12-31$25.13Mn/a2014-12-12, From 2011-01-01